biotech etf Meta: Two of the top pharmaceutical companies on the market announced a major merger today. And it underscores a profit opportunity we’ve been recommending.

Two top pharmaceutical companies announced a merger this morning, continuing 2015's massive run of M&A activity.

Botox maker Allergan Plc. (NYSE: AGN) announced today that it will purchase Kythera Biopharmaceuticals Inc. (Nasdaq: KYTH) for $2.1 billion. That values KYTH shares at $75 each - 24% higher than Tuesday's closing price.

The move highlights one of our favorite profit plays of 2015. It's up 16.7% already and has plenty of room to run...